Consolidation therapy of arsenic trioxide alternated with chemotherapy achieves remarkable efficacy in newly diagnosed acute promyelocytic leukemia

BACKGROUND: Currently, all-trans retinoic acid (ATRA) combined with daunorubicin and ATRA combined with arsenic trioxide (ATO) therapies are considered the standard induction therapy regimens for adult patients newly diagnosed with acute promyelocytic leukemia (APL). However, there is no consensus c...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Onco Targets Ther
Главные авторы: Liu, Cheng-cheng, Wang, Hua, Wang, Wei-da, Zhu, Meng-yuan, Geng, Qi-rong, Lu, Yue
Формат: Artigo
Язык:Inglês
Опубликовано: Dove Medical Press 2015
Предметы:
Original Research
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC4654542/
https://ncbi.nlm.nih.gov/pubmed/26622182
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S92486
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы